BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+16.96%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$1.82B
AUM Growth
+$1.82B
(+25%)
Cap. Flow
+$148M
Cap. Flow
% of AUM
8.16%
Top 10 Holdings %
Top 10 Hldgs %
36.79%
Holding
154
New
14
Increased
82
Reduced
29
Closed
17
Top Buys
| 1 |
Humana
HUM
|
$19.6M |
| 2 |
Evolent Health
EVH
|
$17.1M |
| 3 |
Teladoc Health
TDOC
|
$16.7M |
| 4 |
Bristol-Myers Squibb
BMY
|
$9.97M |
| 5 |
AVDR
Avedro, Inc Common Stock
AVDR
|
$9.2M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$60.4M |
| 2 |
Ionis Pharmaceuticals
IONS
|
$6.49M |
| 3 |
Amgen
AMGN
|
$5.79M |
| 4 |
MacroGenics
MGNX
|
$4.97M |
| 5 |
Insmed
INSM
|
$4.35M |
Sector Composition
| 1 | Healthcare | 91.36% |
| 2 | Industrials | 1.12% |
| 3 | Technology | 0.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Align Technology
ALGN
$10.3B
| $95.2M | 5.24% | 334,679 +23,884 | +8% | +$6.79M |
|
2
Intuitive Surgical
ISRG
$170B
| $86.2M | 4.74% | 150,999 +12,202 | +9% | +$6.96M |
|
3
Abbott
ABT
$231B
| $83.2M | 4.58% | 1,040,587 +64,136 | +7% | +$5.13M |
|
4
Illumina
ILMN
$15.8B
| $80.1M | 4.41% | 257,696 +5,803 | +2% | +$1.8M |
|
|
5
Teladoc Health
TDOC
$1.37B
| $76.4M | 4.2% | 1,374,294 +300,455 | +28% | +$16.7M |
|
6
Elevance Health
ELV
$71.8B
| $73.2M | 4.03% | 255,017 +22,357 | +10% | +$6.42M |
|
7
Danaher
DHR
$147B
| $45.1M | 2.48% | 341,784 +8,888 | +3% | +$1.17M |
|
8
Medtronic
MDT
$119B
| $44.7M | 2.46% | 490,906 -5,540 | -1% | -$505K |
|
9
Boston Scientific
BSX
$156B
| $44M | 2.42% | 1,147,487 +90,598 | +9% | +$3.48M |
|
|
10
Humana
HUM
$36.5B
| $40.6M | 2.23% | 152,477 +73,817 | +94% | +$19.6M |
|
11
Jazz Pharmaceuticals
JAZZ
$7.75B
| $38.2M | 2.1% | 267,438 +6,790 | +3% | +$971K |
|
|
12
Bristol-Myers Squibb
BMY
$96B
| $33.2M | 1.83% | 695,824 +209,000 | +43% | +$9.97M |
|
13
UnitedHealth
UNH
$281B
| $32.8M | 1.81% | 132,837 +1 | +0% | +$247 |
|
14
Becton Dickinson
BDX
$55.3B
| $32.2M | 1.77% | 128,972 +7,100 | +6% | +$1.77M |
|
15
Edwards Lifesciences
EW
$47.8B
| $31M | 1.7% | 161,912 +4,115 | +3% | +$787K |
|
16
Stryker
SYK
$150B
| $29.4M | 1.62% | 148,900 -1,934 | -1% | -$382K |
|
|
WCG
17
DELISTED
Wellcare Health Plans, Inc.
WCG
| $29M | 1.59% | 107,419 +24,215 | +29% | +$6.53M |
|
18
Cigna
CI
$80.3B
| $26.6M | 1.47% | 165,657 +32 | +0% | +$5.15K |
|
19
Qiagen
QGEN
$10.1B
| $25.1M | 1.38% | 617,194 +181,895 | +42% | +$7.4M |
|
20
Alnylam Pharmaceuticals
ALNY
$58.5B
| $25M | 1.37% | 267,305 +42,920 | +19% | +$4.01M |
|
|
21
Ionis Pharmaceuticals
IONS
$6.8B
| $24.6M | 1.35% | 302,643 -79,945 | -21% | -$6.49M |
|
22
Baxter International
BAX
$12.7B
| $23.8M | 1.31% | 293,174 +38,631 | +15% | +$3.14M |
|
|
ALXN
23
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $23.1M | 1.27% | 171,150 +15,470 | +10% | +$2.09M |
|
24
Vertex Pharmaceuticals
VRTX
$100B
| $21.5M | 1.18% | 116,989 +2,289 | +2% | +$421K |
|
|
HRC
25
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $21.5M | 1.18% | 203,088 -1,920 | -0.9% | -$203K |
|